Essais liés2clinical trials
VilleGenoalocalisation
PaysItalylocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT01194570

Ouvrir le site du centre

Essais cliniques associés

2
MoléculeIndication / populationPhaseNCTTitreStatut
Interferon beta-1a SEP Phase 3 NCT01412333 A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis COMPLETED
Ocrelizumab SEP Phase 3 NCT01194570 ORATORIO — A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis COMPLETED